Latest Insider Transactions at Entera Bio Ltd. (ENTX)
This section provides a real-time view of insider transactions for Entera Bio Ltd. (ENTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Entera Bio Ltd. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Entera Bio Ltd.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 02
2024
|
Haya Taitel Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,278
+11.2%
|
-
|
|
Oct 02
2024
|
Sean Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,466
+5.53%
|
-
|
|
Oct 02
2024
|
Gerald M Lieberman Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,269
+4.07%
|
-
|
|
Oct 02
2024
|
Yonatan Malca Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,639
+18.12%
|
-
|
|
Oct 02
2024
|
Gerald M Ostrov Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,452
+17.85%
|
-
|
|
Aug 27
2024
|
Sean Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,061
+13.07%
|
-
|
|
Aug 27
2024
|
Haya Taitel Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,335
+23.31%
|
-
|
|
Aug 27
2024
|
Gerald M Ostrov Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,446
+40.18%
|
-
|
|
Aug 27
2024
|
Yonatan Malca Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,172
+43.25%
|
-
|
|
Aug 27
2024
|
Gerald M Lieberman Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,261
+9.68%
|
-
|
|
Jul 31
2024
|
Miranda Jayne Toledano Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
124,121
+34.57%
|
-
|
|
Apr 19
2024
|
Hillel Galitzer Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,151
+31.94%
|
-
|
|
Apr 19
2024
|
Dana Yaacov Garbeli Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,151
+25.8%
|
-
|
|
Jan 12
2024
|
Haya Taitel Director |
BUY
Open market or private purchase
|
Direct |
9,500
+21.29%
|
$0
$0.99 P/Share
|
|
Jan 10
2024
|
Haya Taitel Director |
BUY
Open market or private purchase
|
Direct |
7,615
+22.92%
|
$0
$0.77 P/Share
|
|
Dec 22
2023
|
Gerald M Lieberman Director |
BUY
Open market or private purchase
|
Direct |
23,952
+9.55%
|
$0
$0.71 P/Share
|
|
Dec 22
2023
|
Miranda Jayne Toledano Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
23,952
+17.78%
|
$0
$0.71 P/Share
|
|
Aug 22
2023
|
Haya Taitel Director |
BUY
Open market or private purchase
|
Direct |
18,000
+50.0%
|
$0
$0.62 P/Share
|
|
Aug 21
2023
|
Gerald M Lieberman Director |
BUY
Open market or private purchase
|
Direct |
20,000
+8.54%
|
$0
$0.59 P/Share
|
|
Aug 21
2023
|
Sean Ellis Director |
BUY
Open market or private purchase
|
Direct |
40,000
+28.15%
|
$0
$0.6 P/Share
|
|
Apr 04
2023
|
Miranda Jayne Toledano Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
30,000
+25.68%
|
$30,000
$1.01 P/Share
|
|
Nov 14
2022
|
Gerald M Lieberman Director |
BUY
Open market or private purchase
|
Indirect |
16,000
+39.22%
|
$0
$0.57 P/Share
|
|
Nov 14
2022
|
Gerald M Lieberman Director |
BUY
Open market or private purchase
|
Direct |
34,000
+14.9%
|
$0
$0.57 P/Share
|
|
Nov 14
2022
|
Dana Yaacov Garbeli Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
26,580
+31.96%
|
$0
$0.54 P/Share
|
|
Nov 11
2022
|
Dana Yaacov Garbeli Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
30,000
+50.0%
|
$0
$0.52 P/Share
|
|
Nov 11
2022
|
Miranda Jayne Toledano Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+46.82%
|
$0
$0.53 P/Share
|
|
Nov 11
2022
|
Sean Ellis Director |
BUY
Open market or private purchase
|
Direct |
30,000
+32.57%
|
$0
$0.53 P/Share
|
|
Jul 21
2022
|
Gerald M Lieberman Director |
BUY
Open market or private purchase
|
Direct |
19,491
+10.85%
|
$19,491
$1.68 P/Share
|
|
Jul 21
2022
|
Sean Ellis Director |
BUY
Open market or private purchase
|
Direct |
14,900
+31.7%
|
$14,900
$1.64 P/Share
|
|
Jan 20
2022
|
Phillip Schwartz President of R&D |
BUY
Open market or private purchase
|
Direct |
10,000
+1.62%
|
$20,000
$2.52 P/Share
|
|
Jan 19
2022
|
Ramesh Ratan U.S.based CFO |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$20,000
$2.44 P/Share
|
|
Jan 18
2022
|
Gerald M Lieberman Director |
BUY
Open market or private purchase
|
Indirect |
2,800
+24.14%
|
$5,600
$2.8 P/Share
|
|
Jan 18
2022
|
Spiros Jamas Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$20,000
$2.85 P/Share
|
|
Jan 18
2022
|
Sean Ellis Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$20,000
$2.81 P/Share
|
|
Jan 18
2022
|
Ron Mayron Director |
BUY
Open market or private purchase
|
Direct |
7,000
+50.0%
|
$14,000
$2.8 P/Share
|
|
Jan 14
2022
|
Miranda Jayne Toledano Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
6,800
+50.0%
|
$13,600
$2.79 P/Share
|
|
Jan 13
2022
|
Gerald M Ostrov Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$20,000
$2.74 P/Share
|
|
Jan 13
2022
|
Yonatan Malca Director |
BUY
Open market or private purchase
|
Direct |
7,232
+50.0%
|
$14,464
$2.74 P/Share
|